Status:
COMPLETED
Bare Metal Stents and Drug Eluting Stents in Patients Who Underwent Blood Transfusion
Lead Sponsor:
Samsung Medical Center
Conditions:
Erythrocyte Transfusion
Percutaneous Coronary Intervention
Eligibility:
All Genders
Brief Summary
Retrospective cohort study of Korean National Healthcare Insurance Database. To investigate clinical outcomes of bare metal stents versus drug eluting stents in patients who underwent periprocedural r...
Detailed Description
A Korean nationwide, multi-center, retrospective observational cohort study. The receipt of red blood cell transfusion is at high risk of cardiac events or death. But little is know regarding the com...
Eligibility Criteria
Inclusion
- Patients with percutaneous coronary intervention from 2006 to 2015
- Patients with the implantation of BMS or DES
- Patients with the receipt of periprocedural red blood cell transfusion
Exclusion
- Patients without any of stent implantation
Key Trial Info
Start Date :
January 3 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2018
Estimated Enrollment :
28322 Patients enrolled
Trial Details
Trial ID
NCT03788148
Start Date
January 3 2018
End Date
November 30 2018
Last Update
December 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, Gang nam-Gu, Ilwon-Dong, South Korea, 135-710